Why Does Biohub Study Systems Instead of One Disease?
Mark Zuckerberg says Biohub studies systems such as inflammation and the immune system, rather than one disease, so other groups can use the tools on specific therapies.
Inflammation is a focus of the Chicago Biohub because it connects to many illnesses. The immune system is a useful case for the cellular engineering work. The stack runs from proteins to cells to a whole system, and immune cells can travel through the body. How to make the immune system function better, and how to connect that last step to a treatment, is work he says biotech companies and individual academics are better suited to do. Biohub's part is the shared tool set that speeds those groups up.
From the transcript
So I don't think that the current set of things that we're aware of are going to be the only things that need to get worked out. But I don't know. I think that the progress with AI is really... is obviously very exciting on this. The other thing that I'd say, just adding to what you were saying a second ago, is we really look at more kind of systems than specific diseases.
So for example, one area that seems really important to understand is inflammation. We talked about this a bunch. This is a big focus of the Chicago Biohub. There's a lot of data on that. It seems quite clear that it's connected to a
Rather than studying the specific diseases, we think that by trying to understand inflammation more broadly, that will make it so that other companies that can then use these tools can work on specific therapies. Another example is, I think that the immune system, I think, is... a very good case to study for some of the work that we're doing in cellular engineering.